O3-05-06: Academic Performance and Risk of Alzheimer's Disease and Dementia in the Nun Study: Are High Grades a Protective Factor or Low Grades a Risk Factor?

2016 ◽  
Vol 12 ◽  
pp. P297-P298
Author(s):  
Suzanne L. Tyas ◽  
Maryam Iraniparast ◽  
Michael L. MacKinley ◽  
Sanduni M. Costa ◽  
Danielle O. Fearon
Dementia ◽  
2017 ◽  
Vol 18 (5) ◽  
pp. 1651-1662
Author(s):  
Kieran Keohane ◽  
Myles Balfe

Data from the Nun Study, the most famous longitudinal epidemiology of Alzheimer’s disease to date, are analyzed and reformulated in terms of Max Weber’s discussion of the centrality of beruf – “calling” – fulfilling a life task in pursuit of a vocation. Qualitative differences in the Nuns’ vocations are uncovered, which are correlated to their resilience to dementia. Extrapolating, we argue that Alzheimer’s disease and the dementia reputed to it should be understood as a social pathology of contemporary civilization related to the loss of moral foundations from which coherent, meaningful life-projects can be conducted.


Author(s):  
Keng Yoon Yeong ◽  
Christine Law

Alzheimer’s disease (AD) is a neurodegenerative disorder that has affected millions of people worldwide. However, currently there is no treatment to cure the disease. The AD drugs available in the market only manage the disease symptomatically and the effects are usually short-term. Thus, there is a need to look at alternatives AD therapies. Mid-life hypertension has not only been recognised as a risk factor for AD, but its relation with AD has also been well established. Thus, antihypertensives are postulated to be beneficial in managing AD. This literature review aims to shed some light on the potential of repurposing antihypertensives to treat AD, considering recent updates. Four classes of antihypertensives, as well as their potential limitations and future prospects in being utilised as AD therapeutics are discussed in this review.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Kaicheng Li ◽  
Xiao Luo ◽  
Qingze Zeng ◽  
Yerfan Jiaerken ◽  
Shuyue Wang ◽  
...  

AbstractThough sleep disturbance constitutes the risk factor for Alzheimer’s disease (AD), the underlying mechanism is still unclear. This study aims to explore the interaction between sleep disturbances and AD on brain function. We included 192 normal controls, 111 mild cognitive impairment (MCI), and 30 AD patients, with either poor or normal sleep (PS, NS, respectively). To explore the strength and stability of brain activity, we used static amplitude of low-frequency fluctuation (sALFF) and dynamic ALFF (dALFF) variance. Further, we examined white matter hyperintensities (WMH) and amyloid PET deposition, representing the vascular risk factor and AD-related hallmark, respectively. We observed that sleep disturbance significantly interacted with disease severity, exposing distinct effects on sALFF and dALFF variance. Interestingly, PS groups showed the dALFF variance trajectory of initially increased, then decreased and finally increased along the AD spectrum, while showing the opposite trajectory of sALFF. Further correlation analysis showed that the WMH burden correlates with dALFF variance in PS groups. Conclusively, our study suggested that sleep disturbance interacts with AD severity, expressing as effects of compensatory in MCI and de-compensatory in AD, respectively. Further, vascular impairment might act as important pathogenesis underlying the interaction effect between sleep and AD.


2009 ◽  
Vol 5 (4S_Part_13) ◽  
pp. P383-P383
Author(s):  
Simon Forstmeier ◽  
Michael Wagner ◽  
Wolfgang Maier ◽  
Hendrik Van Den Bussche ◽  
Birgitt Wiese ◽  
...  

2014 ◽  
Vol 45 (3) ◽  
pp. 247-250 ◽  
Author(s):  
Khaled Nazef ◽  
Malika Khelil ◽  
Hiba Chelouti ◽  
Ghouti Kacimi ◽  
Mohamed Bendini ◽  
...  

2003 ◽  
Vol 23 (11) ◽  
pp. 2055-2062 ◽  
Author(s):  
Alex E. Roher ◽  
Chera Esh ◽  
Tyler A. Kokjohn ◽  
Walter Kalback ◽  
Dean C. Luehrs ◽  
...  

2012 ◽  
Vol 8 (3) ◽  
pp. 196-203 ◽  
Author(s):  
Pamela Sparks Stein ◽  
Michelle J. Steffen ◽  
Charles Smith ◽  
Gregory Jicha ◽  
Jeffrey L. Ebersole ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document